169. SERTOLI CELL-SPECIFIC DISRUPTION OF THE ANDROGEN RECEPTOR DNA-BINDING DOMAIN REVEALS DIFFERENTIAL TEMPORAL CONTROL OF DISTINCT ANDROGEN-REGULATED GENES

2009 ◽  
Vol 21 (9) ◽  
pp. 87
Author(s):  
C. M. Allan ◽  
M. Robson ◽  
T. Harwood ◽  
D. J. Handelsman

Androgen receptor (AR) actions are vital for spermatogenesis. However, in postnatal development male germ cells do not express AR, highlighting its key role in testicular somatic cells. We recently used a Cre-loxP strategy to determine the in vivo requirement of AR DNA-binding in Sertoli cell (SC) function. Transgenic (Tg) mice with Cre expression targeted by SC-specific AMH or Abp promoters were crossed with floxed-Ar (Arflox) mice for Cre-loxP inframe deletion of Ar exon 3, which encodes a zinc finger essential for the DNA-binding domain (DBD). SC-specific mutated ARΔex3 (SCARΔex3) produced infertile AMH.SCARΔex3 and Abp.SCARΔex3 males. Testes from adult homozygous TgCre(+/+) AMH.SCARΔex3 or Abp.SCARΔex3 males were 30% of normal size and exhibited meiotic arrest, whereas testes from hemizygous TgCre(+/–) Abp.SCARΔex3 males were larger (47% normal) with more postmeiotic germ cell development. Despite marked Leydig cell hypertrophy, testicular expression of the adult Leydig marker Hsd3b6 (RT-PCR) and normal intratesticular testosterone levels (LC-MS/MS) in SCARΔex3 males indicated the presence of morphologically distinct but functional adult Leydig cells. SC-specific mutated AR Δex3 was predicted to disrupt classical AR-regulated pathways via loss of direct DNA interaction. Androgen-repressed testicular Ngfr expression (known to be via non-classical AR pathways) was not upregulated in SCARΔex3 testes, suggesting maintenance of a non-classical mechanism independent of AR-DBD. In contrast, SC-specific Rhox5 and Eppin transcription, regulated by divergent or classical androgen-response elements respectively, were both decreased in postnatal SCARΔex3 vs. control testes, demonstrating SC-specific AR function as early as postnatal day 5. However, Rhox5 expression declined dose-dependently, whereas Eppin expression increased, in adult TgCre(+/−) and TgCre(+/+) SCARΔex3 testes, revealing differential temporal control for distinct AR-regulated transcripts. Thus, our SCARΔex3 paradigm displayed dose-dependent TgCre-disruption of meiotic competence and post-meiotic development as well as gene expression, and represents a unique model to selectively differentiate AR-regulated genes.

2008 ◽  
Vol 78 (Suppl_1) ◽  
pp. 54-55
Author(s):  
Charles M. Allan ◽  
Patrick Lim ◽  
Mark Jimenez ◽  
Jennifer Spaliviero ◽  
Kirsten McTavish ◽  
...  

Endocrinology ◽  
2009 ◽  
Vol 150 (10) ◽  
pp. 4755-4765 ◽  
Author(s):  
Patrick Lim ◽  
Mathew Robson ◽  
Jenny Spaliviero ◽  
Kirsten J. McTavish ◽  
Mark Jimenez ◽  
...  

2012 ◽  
Vol 87 (Suppl_1) ◽  
pp. 442-442
Author(s):  
Charles M. Allan ◽  
Tayebeh Rastegar ◽  
Rasmani Hazra ◽  
Xin He ◽  
Reena Desai ◽  
...  

2000 ◽  
Vol 53 (2) ◽  
pp. 83-88 ◽  
Author(s):  
Yvonne Lundberg Giwercman ◽  
Andrej Nikoshkov ◽  
Kristina Lindsten ◽  
Birgitta Byström ◽  
Åke Pousette ◽  
...  

1994 ◽  
Vol 14 (9) ◽  
pp. 6056-6067
Author(s):  
M Tanaka ◽  
W Herr

The POU domain activator Oct-2 contains an N-terminal glutamine-rich transcriptional activation domain. An 18-amino-acid segment (Q18III) from this region reconstituted a fully functional activation domain when tandemly reiterated and fused to either the Oct-2 or GAL4 DNA-binding domain. A minimal transcriptional activation domain likely requires three tandem Q18III segments, because one or two tandem Q18III segments displayed little activity, whereas three to five tandem segments were active and displayed increasing activity with increasing copy number. As with natural Oct-2 activation domains, in our assay a reiterated activation domain required a second homologous or heterologous activation domain to stimulate transcription effectively when fused to the Oct-2 POU domain. These results suggest that there are different levels of synergy within and among activation domains. Analysis of reiterated activation domains containing mutated Q18III segments revealed that leucines and glutamines, but not serines or threonines, are critical for activity in vivo. Curiously, several reiterated activation domains that were inactive in vivo were active in vitro, suggesting that there are significant functional differences in our in vivo and in vitro assays. Reiteration of a second 18-amino-acid segment from the Oct-2 glutamine-rich activation domain (Q18II) was also active, but its activity was DNA-binding domain specific, because it was active when fused to the GAL4 than to the Oct-2 DNA-binding domain. The ability of separate short peptide segments derived from a single transcriptional activation domain to activate transcription after tandem reiteration emphasizes the flexible and modular nature of a transcriptional activation domain.


2017 ◽  
Vol 11 (1) ◽  
pp. 40-45 ◽  
Author(s):  
G. Eastman Welsford ◽  
Rikke Munk ◽  
Daniel A.F. Villagómez ◽  
Poul Hyttel ◽  
W. Allan King ◽  
...  

1993 ◽  
Vol 13 (12) ◽  
pp. 7850-7858
Author(s):  
F Kaspar ◽  
H Klocker ◽  
A Denninger ◽  
A C Cato

Reifenstein syndrome is an eponymic term that describes partial androgen-insensitive disorders. Androgen receptor isolated from five patients with this syndrome contains a specific mutation in the DNA binding domain of the receptor. This mutation converts an alanine to a threonine at position 596 next to the zinc catenation site at the second finger. The threonine 596 mutant receptor mediated normal androgen response at promoters with closely positioned multiple regulatory elements for the androgen receptor and other transcription factors. Promoters with single isolated androgen response elements were not transactivated by the mutant receptor. In in vitro receptor-DNA binding studies, interaction with DNA by the mutant receptor was achieved only in the presence of an anti-androgen receptor antibody. Exchanging alanine 596 in the wild-type androgen receptor with serine or valine produced mutants with properties indistinguishable from those of the naturally occurring threonine 596 mutant receptor. These results indicate that an alanine residue at position 596 contributes important structural and functional activities to the androgen receptor. In the androgen receptor from the patients with Reifenstein syndrome, in which this alanine is converted to a threonine, wild-type receptor properties can be restored by exchanging an additional threonine at position 602 to an alanine. An alanine residue at position 596 or 602 in the DNA binding domain of the androgen receptor is therefore important for the full function of this receptor. In all steroid receptors that bind the core sequence AGAACANNNTGTTCT, an alanine residue is also present at a position equivalent to alanine 596 in the androgen receptor.


2014 ◽  
Vol 57 (15) ◽  
pp. 6458-6467 ◽  
Author(s):  
Huifang Li ◽  
Fuqiang Ban ◽  
Kush Dalal ◽  
Eric Leblanc ◽  
Kate Frewin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document